Navigation Links
Neptune Technologies and Marine Life Sciences enter worldwide distribution alliance with Weider Global Nutrition
Date:9/25/2008

er is a partner of choice for Marine Life Sciences and Neptune, because of its leadership position in the health and fitness industry with brand recognition and impeccable reputation in more than 120 countries," said Dr. Toni Rinow, Corporate Development and Investor Relations of Neptune.

NKO(R) is a proprietary phospholipid omega-3 composition extracted from Antarctic Krill and patented for its extraction process, composition and for its medicinal use. NKO(R)'s safety and health benefits have been demonstrated by clinical studies in hyperlipidemia (high cholesterol), premenstrual syndroms, inflammation and arthritic disease. The development of several functional food product lines as well as pharmaceutical product opportunities for three pharmaceutical markets including the over-the-counter, the prescription medical food and prescription drug market are currently underway.

(1) NBJ 2006 Industry Report

About Neptune

Neptune researches and develops proprietary bioactive ingredients and products for nutraceutical and pharmaceutical applications and is carrying out clinical research to show the therapeutic benefits in various medical indications. The Company patents and protects its innovations and continuously expands its intellectual property portfolio. Neptune has already obtained many regulatory approvals allowing commercialization of its products in various geographic markets and has filed for and is expecting additional approvals. Neptune continues to strongly support its strategic development plan to form partnership with worldwide leaders in the nutraceutical industries. Neptune signed agreements with Nestle and Yoplait, worldwide leading food manufacturers, and paved its entrance into the global functional food market.

Neither NASDAQ nor TSX Venture Exchange accepts responsibility for the

adequacy or accuracy of this press release.

Statements in this press release that are not statements of historical or current
'/>"/>

SOURCE NEPTUNE TECHNOLOGIES & BIORESSOURCES INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Neptune Krill Oil, NKO(R), enters WALGREENS, the largest U.S. retail pharmacy chain, under the brand name Schiff(R) MegaRed(TM)
2. Neptune Technologies decided not to re-price options
3. Neptune Technologies successfully completes up to $8.5 million debt financing with Desjardins Group
4. Neptune Technologies Reports Record Fiscal 2008 Fourth Quarter and Year End Results
5. Neptune Technologies & Bioressources Inc. reports third quarter results and update on strategic milestones
6. The Omega-3 Industry Leader, Croda Health Care, selects Neptune Technologies Ingredients for New Essentially Brand
7. Neptune Technologies patent granted for novel phospholipids in multiple diseases and pharmaceutical applications
8. Neptune Technologies expands into medicinal markets in Asia Pacific
9. Neptune Technologies receives GRAS notification in the United States
10. Neptune Technologies & Bioressources Inc. obtains Complementary Medicine approval in Australia for NKO(R)
11. Neptune Technologies & Bioressources Inc. Secures Access to Nationwide Consumer Mass Market in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... - Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS), a ... target the underlying mechanisms of cancer, today reported financial ... 31, 2014. Effective July 17, 2014, the ... to December 31. As a result of that change, ... quarter and the seven months ended December 31, 2014, ...
(Date:3/3/2015)... NASA astronaut Scott Kelly , who is ... a year living and working on the International Space Station, ... 7 a.m. EDT Monday, March 9. Kelly will ... the final weeks of his training. The interviews will be ... highlighting his mission training and previous spaceflights. To ...
(Date:3/3/2015)... BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced several ... projects in North America , the ... "Bidding activity in 2015 continues to be robust" said ... year for bidding in 2014, we are pleased to see the ... the organization,s renewed focus on select market segments where we can ...
(Date:3/3/2015)... -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced ... Executive Officer of Neurocrine Biosciences, will be presenting at ... The live presentation takes place on Tuesday, March ... be webcast and may be accessed on the Company,s ... are encouraged to visit the website approximately 5 minutes ...
Breaking Biology Technology:Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 2Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 7Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 8Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 9Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 10Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 11Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 12NASA Astronaut Scott Kelly Available for Interviews before One-Year Space Station Mission 2
... BERKELEY HEIGHTS, N.J., Oct. 18 Genta,Incorporated (Nasdaq: ... preclinical,data on Genasense(R) (oblimersen sodium) Injection, its lead ... and Therapeutics",conference that will take place from October ... is jointly sponsored by the U.S. National Cancer,Institute ...
... Consortium today published analyses of its second-generation map ... more markers than the initial version unveiled in ... the consortium describes how the higher resolution map ... in common diseases, explore the structure of human ...
... BioMarin,Pharmaceutical Inc. (Nasdaq and SWX: BMRN) announced ... dihydrochloride), Naglazyme(R),(galsulfase), and Aldurazyme(R) (laronidase) will be presented ... of Human Genetics in San Diego,California, October 23-27, ... below:, Platform Presentation - Session 59 - ...
Cached Biology Technology:Genta Announces Presentation of New Clinical and Preclinical Data on Genasense(R) at AACR-NCI-EORTC 'Targets' Conference 2Genta Announces Presentation of New Clinical and Preclinical Data on Genasense(R) at AACR-NCI-EORTC 'Targets' Conference 3Consortium publishes Phase II map of human genetic variation 2Consortium publishes Phase II map of human genetic variation 3Consortium publishes Phase II map of human genetic variation 4Consortium publishes Phase II map of human genetic variation 5Consortium publishes Phase II map of human genetic variation 6Kuvan, Naglazyme and Aldurazyme Data to Be Presented at the 57th Annual Meeting of the American Society of Human Genetics 2Kuvan, Naglazyme and Aldurazyme Data to Be Presented at the 57th Annual Meeting of the American Society of Human Genetics 3Kuvan, Naglazyme and Aldurazyme Data to Be Presented at the 57th Annual Meeting of the American Society of Human Genetics 4
(Date:2/24/2015)... NEW YORK , Feb. 24, 2015 This ... Thousands. The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... America . Annual estimates and forecasts are provided for ... is provided for these markets. Market data and analytics are ...
(Date:2/19/2015)... 2015 Research and Markets ( ... "Military Electro-Optical / Infrared Systems Market by ... - Forecast to 2020" report to their ... market is expected to reach $16.35 billion by ... This report segments the military electro-optical/infrared systems ...
(Date:2/12/2015)... , Feb. 12, 2015 NXT-ID, Inc. ... the "Company"), a biometric authentication company focused on the ... filed provisional patent 62/113114 for DISTRIBUTED METHOD ... The patent further establishes NXT-ID,s position in ... intellectual property portfolio the ability for multiple devices to ...
Breaking Biology News(10 mins):World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 2Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 3NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3
... Bacteria normally found 30km above the earth have been ... stratosphericus a microbe commonly found in high concentrations ... is a key component of a new ,super, biofilm that ... University. , Isolating 75 different species of bacteria from the ...
... muscle . . . ,Researchers at the Bio-SANS ... variation and small-angle neutron scattering to get a first ... synthetic complexes. The unique properties of polyelectrolyte materials are ... of membrane -- three-dimensional bio-scaffolds to grow cells for ...
... One of the greatest biological threats to tropical coral reefs ... ( Acanthaster planci ). Outbreaks can consume live corals over ... reef fish populations, and reduce the aesthetic value of coral ... 30 years of research, the triggers and spread of COT ...
Cached Biology News:Superbugs from space offer new source of power 2Feb. 21, 2012, story tips 2Feb. 21, 2012, story tips 3Coral-eating sea star invaders turn out to be locals 2
This application changes sensitive keywords in an FCS file to remove patient information. It was contributed by Dr. David Miller....
Rat monoclonal [HK5.3] to B7 RP1 (Biotin) ( Abpromise for all tested applications). entrezGeneID: 23308 SwissProtID: O75144...
Zinc finger MYM-type protein 3 (Zinc finger protein 261) (DXS6673E protein). [Source:Uniprot/SWISSPROT;Acc:Q14202] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Human Ig Lambda-chain, clone ICO-16, Monoclonal Antibody...
Biology Products: